SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid intense community speculation regarding institutional adoption, integration with global banking rails, and the potential passage of the Clarity Act. Investors are actively debating the token's long-term utility against market volatility, with many monitoring institutional ETF inflows and upcoming partnerships for signs of a breakout.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for community debate, driven by a recent Google research paper highlighting its quantum-resistant technology and ongoing institutional adoption discussions. While some investors remain highly bullish on its long-term potential and infrastructure utility, others are actively criticizing its price performance and expressing skepticism regarding a significant recovery.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently facing significant volatility driven by concerns over its recent convertible notes offering and CEO stock sales, leading to community frustration regarding management execution despite the long-term potential of its Casgevy commercialization and diverse gene-editing pipeline. Investors are actively debating the likelihood of a buyout or strategic partnership, while some utilize the dip to accumulate shares based on belief in the company's strong cash position and upcoming 2026 clinical data readouts.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for investors as the community anticipates the impact of upcoming clinical data readouts and the potential lifting of regulatory holds. Traders are actively debating whether these binary events will trigger a significant short squeeze given the high short interest, or if broader biotech market volatility will maintain pressure on the stock price.

TokenFi aims to simplify the crypto and asset tokenization process and eventually become the foremost tokenization platform in the world.  The tokenization industry is projected to be a $16 trillion industry by the year 2030. BlackRock, the world’s biggest institutional investor with $10 trillion of assets under management, strongly believes in the industry’s potential, which they call "the next evolution in markets”.  TokenFi is launched by the highly experienced and connected Floki team that launched the popular Floki token that went to an ATH valuation of $3.5 billion. They will be leveraging this same experience to make TokenFi the number one tokenization platform in the industry.

TokenFi

TokenFi is gaining traction as community members highlight its role in the expanding Real World Asset (RWA) and tokenization sector, specifically pointing to recent exchange listings and the ongoing development of its ecosystem. The community remains highly focused on the project's utility, frequent product updates, and its close strategic ties to the Floki ecosystem.

FLOKI is a community-driven, multi-chain utility token that powers a broad ecosystem including decentralized gaming, finance, and educational platforms. Originally evolving from a meme-based asset, the project now focuses on a utility-driven model centered around three pillars: community engagement, technical utility, and global charity work, balancing this ecosystem growth with social impact, such as building schools in developing nations like Ghana and Nigeria.  Key features include Valhalla, an NFT metaverse game where the token serves as the primary currency for capturing creatures and upgrading characters. The ecosystem also features the FlokiFi Locker for securing digital assets and the University of FLOKI for web3 education,with real-world integration facilitated through a prepaid debit card for everyday purchases at global stores. Staking FLOKI allows users to earn rewards in a sister token.  The project is led by a group of core advisors known by pseudonyms such as Sabre and B (The Viking) and is officially backed by DWF Labs, a major digital asset investment firm and market maker. While a small tax on decentralized trades helps fund development, value moves through the system as users utilize the token to pay for in-game items, access asset-locking services, or purchase merchandise.

Floki Token

Floki is capturing community attention as holders weigh the impact of recent ecosystem expansions, including exchange-traded product listings and new trading bot features, against broader market volatility. Discussions are heavily focused on the token's long-term utility, development milestones like Valhalla, and a collective belief in a pending altcoin market rotation.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as the community anticipates ASH conference data readouts, with investors actively discussing potential M&A synergies between the company and Incyte. Strong clinical trial momentum, coupled with a belief that the stock remains undervalued relative to its oncology peers, has driven bullish sentiment and intense options activity.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant downward pressure as investors rotate out of software stocks, fueling intense community debate over whether the platform's workflow-based moat is being rendered obsolete by new AI design tools. Sentiment remains sharply divided, with bulls pointing to strong institutional accumulation and long-term enterprise stickiness, while bears focus on accelerating competitive threats and the stock's persistent post-IPO decline.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending following its Q4 2025 earnings report, which highlighted strong IBSRELA revenue growth and increased 2026 operating expenses, dividing community opinion while insider buying and a new LPGA partnership add to the conversation.

JetBlue Airways Corp. engages in the provision of air transportation services. Its brands include jetBlue, jetBlue Vacations, Paisly, and TrueBlue. It operates through the following geographic segments: Domestic and Canada, Caribbean and Latin America, and Atlantic. The company was founded by David Gary Neeleman in August 1998 and is headquartered in Long Island City, NY.

Jetblue Airways Corp

JetBlue is experiencing significant market movement driven by ongoing speculation regarding potential consolidation and merger discussions, despite facing persistent regulatory scrutiny. The community is actively debating the company's long-term financial health and the likelihood of a strategic acquisition versus the risks of debt-heavy standalone operations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's in the Cards for Unum Group This Earnings Season?

UNM's Q1 results are likely to reflect stable overall persistency, higher sales, higher invested assets and in-force block growth.

Globe Life (GL) Q1 Earnings and Revenues Miss Estimates

Globe Life (GL) delivered earnings and revenue surprises of -0.98% and -0.38%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Aflac (AFL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Aflac (AFL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TABR Capital Management LLC Makes New $5.77 Million Investment in Unum Group $UNM

TABR Capital Management LLC acquired a new stake in Unum Group (NYSE:UNM - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities...

Unum (UNM) Earnings Expected to Grow: Should You Buy?

Unum (UNM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Unum Group (UNM) to Release Earnings on Tuesday

Unum Group (NYSE:UNM) will be releasing its Q1 2026 earnings after the market closes on Tuesday, April 28. (View Earnings Report at...

Unum Group (NYSE:UNM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Unum Group (NYSE:UNM - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the fourteen ratings firms that are covering the company, MarketBeat.com reports. Seven analysts...

21,573 Shares in Unum Group $UNM Purchased by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. purchased a new position in Unum Group (NYSE:UNM - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 21,573 shares of the financial services provider's stock, valued at approximately $1,67...

24,491 Shares in Unum Group $UNM Acquired by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. acquired a new position in shares of Unum Group (NYSE:UNM - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange...

Robeco Institutional Asset Management B.V. Sells 88,373 Shares of Unum Group $UNM

Robeco Institutional Asset Management B.V. decreased its position in Unum Group (NYSE:UNM - Free Report) by 41.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 126,091 shares of the financial services pro...

Unum Group engages in the provision of financial protection benefits. Its services include disability, life, accident, critical illness, dental, vision, and other related services. It operates through the following segments: Unum US, Unum International, Colonial Life, Closed Block, and Corporate. The Unum US segment focuses on group disability, group life and accidental death and dismemberment products, and supplemental and voluntary lines of business. The Unum International segment engages in the operations of the UK business, which includes insurance for group long-term disability, group life, and supplemental lines of business that include dental, individual disability, and critical illness products. The Colonial Life segment includes insurance for accident, sickness, disability products, life products, and cancer and critical illness products. The Closed Block segment consists of individual disability, group and individual long-term care, and other insurance products no longer actively marketed. The Corporate segment refers to investment income on corporate assets and other corporate income and expenses not allocated to a line of business. The company was founded in 1848 and is headquartered in Chattanooga, TN.

Current Price	$77.48
Prev Close	$77.30
Open	$76.92
Dividend Yield	2.27%
50-Day Moving Average	$74.39
Beta	0.67
Avg. Volume	2.01M
PE Ratio	18.23

52-Week High	$83.13
52-Week Low	$68.28
Market Capitalization	$12.56B
EPS (Annual)	$4.27
Price to Book	1.15
Revenue Per Employee	$1.2M

UNM
Unum Group

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UNM News

UNMUnum Group